RYTM Competitors & Alternatives
Compare Rhythm Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RYTM
Main Stock$89.55
Tradestie Score
70
Market Cap
$6.64B
Revenue Growth
0.5%
Analyst Upside
+60.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$62.58
|
$6.68B | - | 61 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$89.26
|
$6.38B | - | 61 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.75
|
$6.03B | - | 45 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$49.93
|
$6.02B | - | 66 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$155.79
|
$5.92B | - | 49 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$52.91
|
$5.80B | 19.8 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$318.97
|
$5.20B | 40.8 | 64 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$62.35
|
$4.94B | - | 42 | Compare |
More RYTM Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry